trial · primary record
Clazakizumab
Atherosclerosis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2027-10 |
| Primary endpoint | Percent Change from Baseline in hsCRP |
| Registry ID | NCT07783802 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:58.028Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07783802
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.